A. B. Iskit Et Al. , "Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels," VASCULAR PHARMACOLOGY , vol.46, no.2, pp.129-136, 2007
Iskit, A. B. Et Al. 2007. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels. VASCULAR PHARMACOLOGY , vol.46, no.2 , 129-136.
Iskit, A. B., Erkent, U., Ertunc, M., Guc, M., Ilhan, M., & Onur, R., (2007). Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels. VASCULAR PHARMACOLOGY , vol.46, no.2, 129-136.
Iskit, ALPER Et Al. "Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels," VASCULAR PHARMACOLOGY , vol.46, no.2, 129-136, 2007
Iskit, ALPER B. Et Al. "Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels." VASCULAR PHARMACOLOGY , vol.46, no.2, pp.129-136, 2007
Iskit, A. B. Et Al. (2007) . "Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels." VASCULAR PHARMACOLOGY , vol.46, no.2, pp.129-136.
@article{article, author={ALPER BEKTAŞ İSKİT Et Al. }, title={Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels}, journal={VASCULAR PHARMACOLOGY}, year=2007, pages={129-136} }